Exchange Traded Concepts, LLC Horizon Therapeutics Public LTD CO Transaction History

Exchange Traded Concepts, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	SELL	$62.39 - $113.8 $10,855 - $19,801	-174 Reduced 5.63%	2,917 $332,000
Q3 2022 Oct 07, 2022	BUY	$58.92 - $84.67 $182,121 - $261,714	3,091 New	3,091 $191,000
Q1 2022 Apr 26, 2022	SELL	$86.42 - $109.81 $420,260 - $534,006	-4,863 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$98.56 - $119.91 $479,297 - $583,122	4,863 New	4,863 $524,000
Q3 2021 Oct 18, 2021	SELL	$91.91 - $110.37 $790,242 - $948,961	-8,598 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$86.24 - $95.92 $718,206 - $798,821	8,328 Added 3084.44%	8,598 $805,000
Q1 2021 Apr 20, 2021	SELL	$71.83 - $95.48 $78,007 - $103,691	-1,086 Reduced 80.09%	270 $25,000
Q4 2020 Jan 19, 2021	BUY	$67.0 - $84.39 $81,405 - $102,533	1,215 Added 861.7%	1,356 $99,000
Q3 2020 Oct 30, 2020	BUY	$55.23 - $79.93 $5,633 - $8,152	102 Added 261.54%	141 $11,000
Q2 2020 Jul 15, 2020	BUY	$30.2 - $56.98 $1,177 - $2,222	39 New	39 $2,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.